Growth Metrics

Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 95.07%
Dec 31, 2025 102.56%
Sep 30, 2025 4.54%
Jun 30, 2025 1.40%
Mar 31, 2025 -17.01%
Dec 31, 2024 5.69%
Sep 30, 2024 -3.76%
Jun 30, 2024 -5.17%
Mar 31, 2024 -5.25%
Dec 31, 2023 -5.57%
Sep 30, 2023 -5.95%
Jun 30, 2023 -7.18%
Mar 31, 2023 -7.08%
Dec 31, 2022 -7.51%
Sep 30, 2022 -7.21%
Jun 30, 2022 -6.84%
Mar 31, 2022 -6.41%
Dec 31, 2021 -6.22%
Sep 30, 2021 -6.70%
Jun 30, 2021 -5.74%
Mar 31, 2021 6.51%
Dec 31, 2020 8.71%
Sep 30, 2020 26.02%
Jun 30, 2020 31.40%
Mar 31, 2020 60.03%
Dec 31, 2019 -2.12%
Sep 30, 2019 -5.19%
Jun 30, 2019 -8.30%
Mar 31, 2019 12.93%
Dec 31, 2018 -1.87%
Sep 30, 2018 22.17%
Jun 30, 2018 1.88%
Mar 31, 2018 1.77%
Dec 31, 2017 -11.00%
Sep 30, 2017 -9.25%
Jun 30, 2017 -5.04%
Mar 31, 2017 12.66%
Dec 31, 2016 -2.47%
Sep 30, 2016 9.04%
Jun 30, 2016 10.45%
Mar 31, 2016 19.06%
Dec 31, 2015 6.53%
Sep 30, 2015 14.07%
Jun 30, 2015 1.51%
Mar 31, 2015 222.97%
Dec 31, 2014 6.35%
Sep 30, 2014 4.00%
Jun 30, 2014 -7.92%
Mar 31, 2014 -6.22%
Dec 31, 2013 18.16%
Sep 30, 2013 432.61%
Jun 30, 2013 206.67%
Mar 31, 2013 -28.57%
Dec 31, 2012 -33.33%
Sep 30, 2012 -31.52%
Jun 30, 2012 -23.97%
Mar 31, 2012 -19.87%
Dec 31, 2011 -16.57%
Sep 30, 2011 -12.98%